CAMP, cathelicidin antimicrobial peptide, 820

N. diseases: 262; N. variants: 0
Disease: Recurrent urinary tract infection ×
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0262655
Disease: Recurrent urinary tract infection
Recurrent urinary tract infection 		0.030 Biomarker disease BEFREE We suggest that the employment of combination of natural peptide LL-37 with synthetic analogs might be a potential solution to treat urinary tract infections caused by drug-resistant bacteria. 31046689 2019
CUI: C0262655
Disease: Recurrent urinary tract infection
Recurrent urinary tract infection 		0.030 Biomarker disease BEFREE The impact of cathelicidin, the human antimicrobial peptide LL-37 in urinary tract infections. 29310594 2018
CUI: C0262655
Disease: Recurrent urinary tract infection
Recurrent urinary tract infection 		0.030 Biomarker disease BEFREE In addition, clinical E. coli strains that were more resistant to LL-37 caused more severe urinary tract infections than did susceptible strains. 16751768 2006